This story was originally published in The Highlight, Vox’s member-exclusive magazine. To get early access to ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Ugandan authorities launched on Monday a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

The first participants have been vaccinated with an investigational Ebola Sudan vaccine candidate provided by IAVI, a nonprofit scientific ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies, today highlighted that it is committed to playing a pivotal role in reinforcing ...